StockGlow

Medicus Pharma Ltd. (MDCX)

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States.

$0.28+0.05%Healthcare
Compare MDCX with
StockGlow Score
49
Neutral
BearishBullish
1 year ago-89.3%

The outlook

Medicus Pharma Ltd. currently reads as neutral based on strong buy — 1.3 avg of 4 analysts, below its 50- & 200-day averages, 1% of the way from its 52-week low to high, avg target +1535% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusStrong Buy — 1.3 avg of 4 analysts
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +1535% vs current price

Analyst price target

~12-month · 4 analysts
$4.50average target+1535.2% vs now
Now $0.28
Low $1.00High $9.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$15.6M
52-wk high
$3.05
52-wk low
$0.25
50-day avg
$0.37
200-day avg
$1.04
Trailing P/E
—

Similar stocks

BNZIBanzai International, Inc.$1.85+1.65%FMSTForemost Clean Energy Ltd.$1.38-4.17%VWAVVisionWave Holdings, Inc.$1.72-11.34%MAIAMAIA Biotechnology, Inc.$1.25+0.00%SAFXXCF Global, Inc.$0.36-3.77%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy